Prabhakaran B. Nair Appointed Global Chief Manufacturing Officer of Cipla

MUMBAI, June 2, 2025 – Cipla Ltd. (NSE: CIPLA, BSE: 500087) announced that it has elevated Mr. Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer (GCMO) and designated him as Senior Management Personnel (SMP), effective July 1, 2025.

Veteran Pharma Leader to Drive Global Manufacturing Excellence

Mr. Nair is currently the Chief of Quality at Cipla’s Indore plant and has over 34 years of expertise in pharmaceutical manufacturing and quality operations.

Prior to Cipla, Nair served as Chief Operating Officer at Encube Ethicals, where he led major expansions at Goa and Indore. He also held senior leadership roles at ACG Worldwide, Dr. Reddy’s Laboratories, IPCA Laboratories, and Cadila Pharmaceuticals.

Proven Track Record in Quality & Regulatory Excellence

At Cipla, Mr. Nair has been instrumental in improving regulatory audit readiness and incorporating AI-driven frameworks into quality operations. His efforts have fortified the company’s global quality standards and positioned Cipla’s plants for sustained compliance and operational excellence.

He holds a Master of Pharmacy and an MBA from Mumbai University, reinforcing his domain expertise with strategic acumen.

Strategic Outlook

Cipla aims to enhance its global manufacturing capabilities amid growing international demand and evolving regulatory frameworks. The appointment of Mr. Nair’s will help Cipla through his operational depth and leadership experience. This move aligns with Cipla’s long-term vision of transforming its manufacturing footprint with technology-led and quality-first initiatives.

REF: https://nsearchives.nseindia.com/corporate/CIPLA_01062025191326_AppointmentofSMPJune2025signed.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. Every effort is made to ensure the accuracy, relevance, and timeliness of the information provided. However, inadvertent errors or omissions may occasionally occur.

Should you have any concerns, queries, or wish to point out any discrepancies in our content, please write to us at content@hdfcsec.com. Your feedback is valuable and helps us maintain the highest standards of content integrity.

Please note that the information shared is intended solely for informational purposes and should not be construed as investment advice. Users are advised to consult their financial advisors before making any investment decisions.